We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

234 hedge funds and large institutions have $384M invested in Editas Medicine in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 60 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $5.68M | Put options by funds: $4.54M

15% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 60

2.6% less ownership

Funds ownership: 78.6% → 76% (-2.6%)

6% less funds holding

Funds holding: 250 → 234 (-16)

17% less capital invested

Capital invested by funds: $465M → $384M (-$80.9M)

30% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 43

Holders
234
Holders Change
-16
Holders Change %
-6.4%
% of All Funds
3.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
69
Reduced
60
Closed
43
Calls
$5.68M
Puts
$4.54M
Net Calls
+$1.14M
Net Calls Change
-$3.76M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$7.19M
2
Citadel Advisors
Citadel Advisors
Florida
+$7.14M
3
WP
Woodline Partners
California
+$5.05M
4
CSS
Cubist Systematic Strategies
Connecticut
+$3.73M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.93M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$9.76M
2
State Street
State Street
Massachusetts
-$9.41M
3
Millennium Management
Millennium Management
New York
-$7.63M
4
PHS
PFM Health Sciences
California
-$3.79M
5
Man Group
Man Group
United Kingdom
-$3.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
176
Cambridge Trust
Massachusetts
$7.25K – – –
CTC
177
Central Trust Company
Missouri
$7.25K – – –
CUAMC
178
China Universal Asset Management Company
China
$6.78K +$2.11K +237 +34%
BAM
179
Belpointe Asset Management
Nevada
$6.37K -$13.9K -1,560 -64%
FDCDDQ
180
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.08K – – –
TIM
181
Tortoise Investment Management
New York
$4.97K – – –
HCM
182
Hollencrest Capital Management
California
$4.46K – – –
Carson Wealth (CWM LLC)
183
Carson Wealth (CWM LLC)
Nebraska
$4K +$2.13K +239 +84%
TPCW
184
TD Private Client Wealth
New York
$3.9K – – –
FFA
185
Fairfield Financial Advisors
Massachusetts
$3.83K – – –
AWM
186
Ameliora Wealth Management
Switzerland
$3.63K – – –
HI
187
Harbour Investments
Wisconsin
$3.55K +$18 +2 +0.4%
MWM
188
Mascoma Wealth Management
New Hampshire
$3.5K – – –
First Manhattan
189
First Manhattan
New York
$3.21K – – –
WT
190
Washington Trust
Rhode Island
$3.21K – – –
EWM
191
Endurance Wealth Management
Rhode Island
$3K – – –
GWM
192
Geneos Wealth Management
Colorado
$2.9K – – –
AF
193
Allworth Financial
California
$2.9K +$889 +100 +33%
FA
194
Financial Avengers
California
$2.31K – – –
AIP
195
Ahrens Investment Partners
Louisiana
$2.31K +$2.83K +318 New
ICM
196
Islay Capital Management
Texas
$2.17K – – –
SN
197
Sittner & Nelson
Oregon
$2.17K – – –
WT
198
Whittier Trust
California
$2.16K – – –
Daiwa Securities Group
199
Daiwa Securities Group
Japan
$2K – – –
BTI
200
Blue Trust Inc
Georgia
$2K +$400 +45 +23%
6 7
8
9 10

EDIT Hedge Fund Activity: Q1 2023 in Review

234 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2023, worth a combined $384M — down 17% from $465M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of EDIT and 30 opened new positions — a net loss of 13 holders — while 60 trimmed existing stakes and 69 added.

The largest buyer was Pictet Asset Management (Switzerland), adding an estimated $7.19M. The largest seller was Capital World Investors, exiting entirely with an estimated $9.76M sold.

  • 234 institutional investors held Editas Medicine (EDIT) as of Q1 2023, down from 250 in Q4 2022.
  • Funds reported $384M of Editas Medicine stock for Q1 2023, down 17% quarter-over-quarter.
  • 30 funds opened new Editas Medicine positions in Q1 2023 and 43 closed out, a net change of -13 holders.
  • The largest Editas Medicine buyer in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $7.19M added.
  • The largest Editas Medicine seller in Q1 2023 was Capital World Investors, an estimated $9.76M sold.

Based on aggregated 13F filings for Q1 2023.